Losken Albert, Styblo Toncred M, Schaefer Timothy G, Carlson Grant W
Emory Division of Plastic and Reconstructive Surgery, Atlanta, GA 30308, USA.
Ann Plast Surg. 2008 Jul;61(1):24-9. doi: 10.1097/SAP.0b013e318156621d.
The skin sparing mastectomy continues to allow improvement in the esthetic outcome after immediate autologous breast reconstruction. However, native skin flap necrosis does occur and can significantly jeopardize the result. The purpose of this series was to evaluate objectively the utility of fluorescein dye as a tool to assist with evaluation of eventual flap viability or flap necrosis.
Fifty consecutive periareolar mastectomy flaps were evaluated after autologous reconstruction. Patient demographics and risk factors were queried. The mastectomy skin flaps were evaluated clinically for viability and managed appropriately. Flap inset was performed. Intravenous fluorescein dye was then given, and areas of nonfluorescence were marked (size and location documented). Photodocumentation was performed intraoperatively and 1 week postoperatively. Areas of skin survival and skin necrosis were documented, and comparisons were made.
The type of reconstructions included TRAM flap (n = 31), and latissimus dorsi with expander (n = 19), with an average age of 50 years (range: 38-68 years). Patient demographics included previous radiation therapy (n = 5), smoking history (n = 14), hypertension (n = 13), and previous breast scars (n = 16). Skin fluorescence corresponded with flap survival (n = 48/50), giving a positive predictive value of 96%. Two flaps (1 patient) had some skin necrosis despite full fluorescence; however, she was eventually diagnosed with hepatitis C vasculitis. Of the 21 flaps with areas of nonfluorescence, skin necrosis was present in 5 of 21, a negative predictive value of 25%. The majority of areas of nonfluorescence were less than 4 cm2 and had full flap survival (n = 16/21). Two flaps with nonfluorescence of <4 cm2 and previous radiation therapy had skin necrosis. All flaps with areas >4 cm2 had skin necrosis, unless proximally located on the skin flaps.
Fluorescein dye is a sensitive test for determining native mastectomy skin flap viability after autologous reconstruction; however, viability is underpredicted. Location on the skin flaps, size of nonfluorescence, as well as history of radiation therapy should be taken into consideration. Areas of nonfluorescence <4 cm2 typically survive, except in the irradiated breast. Any area of nonfluorescence >4 cm2 typically does not survive, except when located more proximally on the flap.
保留皮肤的乳房切除术在即刻自体乳房重建后仍能改善美学效果。然而,自体皮瓣坏死确实会发生,并且会严重影响手术结果。本系列研究的目的是客观评估荧光素染料作为一种辅助评估最终皮瓣存活或坏死情况的工具的效用。
对50例连续进行乳晕周围乳房切除术后自体重建的皮瓣进行评估。询问患者的人口统计学资料和危险因素。对乳房切除皮瓣的存活情况进行临床评估并给予适当处理。进行皮瓣植入。然后静脉注射荧光素染料,并标记无荧光区域(记录大小和位置)。术中及术后1周进行拍照记录。记录皮肤存活和坏死区域,并进行比较。
重建类型包括横行腹直肌肌皮瓣(TRAM瓣,n = 31)和背阔肌肌皮瓣联合扩张器(n = 19),平均年龄50岁(范围:38 - 68岁)。患者人口统计学资料包括既往放疗史(n = 5)、吸烟史(n = 14)、高血压(n = 13)和既往乳房瘢痕(n = 16)。皮肤荧光与皮瓣存活情况相符(n = 第48/50),阳性预测值为96%。2例皮瓣(1例患者)尽管荧光显示完全,但仍有一些皮肤坏死;然而,她最终被诊断为丙型肝炎血管炎。在21例有非荧光区域的皮瓣中,21例中有5例出现皮肤坏死,阴性预测值为25%。大多数非荧光区域面积小于4 cm²且皮瓣完全存活(n = 16/21)。2例非荧光区域面积小于4 cm²且有既往放疗史的皮瓣出现皮肤坏死。所有非荧光区域面积大于4 cm²的皮瓣均出现皮肤坏死,除非位于皮瓣近端。
荧光素染料是评估自体重建后乳房切除自体皮瓣存活情况的一种敏感检测方法;然而,对存活情况的预测可能不足。应考虑皮瓣上的位置、非荧光区域的大小以及放疗史。非荧光区域面积小于4 cm²通常能存活,但放疗过的乳房除外。任何非荧光区域面积大于4 cm²通常不能存活,除非位于皮瓣更近端的位置。